Pfizer Inc insider trades: Pyxis Oncology (PYXS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Pfizer Inc reports to the SEC
and 12 more companies
Open-market buys and sales
25 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 17, 2023 | PYXS | ↑ Buy | 1,811,594 | $2.76 | $5.0M | Direct | Mar 21, 2023 (4d) |
| Oct 27, 2020 | CERF | ↑ Buy | 1,200,000 | $10.00 | $12.0M | Direct | Oct 29, 2020 (2d) |
| Jun 3, 2020 | CRTX | ↓ Sell | 370,000 | $40.18 | $14.9M | Direct | Jun 4, 2020 (1d) |
| Mar 16, 2020 | IMRA | ↑ Buy | 312,500 | $16.00 | $5.0M | By Pfizer Ventures (US) LLC | Mar 16, 2020 (0d) |
| Sep 17, 2019 | SWTX | ↑ Buy | 50,000 | $18.00 | $900K | Direct | Sep 19, 2019 (2d) |
| May 13, 2019 | CRTX | ↑ Buy | 50,000 | $17.00 | $850K | Direct | May 14, 2019 (1d) |
| Nov 15, 2018 | ICUI | ↓ Sell | 2,500,000 | $209.25 | $523.1M | - | Nov 16, 2018 (1d) |
| Oct 15, 2018 | ALLO | ↑ Buy | 55,556 | $18.00 | $1.0M | Direct | Oct 17, 2018 (2d) |
| Aug 13, 2018 | ICUI | ↓ Sell | 700,000 | $284.35 | $199.0M | _ | Aug 15, 2018 (2d) |
| Oct 10, 2017 | RYTM | ↑ Buy | 40,000 | $17.00 | $680K | Direct | Oct 10, 2017 (0d) |
| Oct 6, 2015 | MIRN | ↑ Buy | 714,285 | $7.00 | $5.0M | Direct | Oct 7, 2015 (1d) |
| Aug 10, 2015 | AQXP | ↓ Sell | 259,927 | $26.47 | $6.9M | Direct | Aug 12, 2015 (2d) |
| Mar 12, 2014 | AQXP | ↑ Buy | 272,727 | $11.00 | $3.0M | Direct | Mar 14, 2014 (2d) |
| Feb 4, 2014 | CLDN | ↑ Buy | 227,261 | $8.00 | $1.8M | Direct | Feb 6, 2014 (2d) |
| Oct 27, 2011 | ICGN | ↑ Buy | 2,743,269 | $6.00 | $16.5M | Direct | Nov 2, 2011 (6d) |
| Sep 19, 2011 | ICGN | ↑ Buy | 66,619 | $6.00 | $400K | Fn | Sep 20, 2011 (1d) |
| Sep 15, 2011 | ICGN | ↑ Buy | 232,203 | $6.00 | $1.4M | Fn | Sep 16, 2011 (1d) |
| Sep 12, 2011 | ICGN | ↑ Buy | 422,023 | $6.00 | $2.5M | Fn | Sep 14, 2011 (2d) |
| Sep 9, 2011 | ICGN | ↑ Buy | 60,614 | $6.00 | $364K | Fn | Sep 12, 2011 (3d) |
| Sep 2, 2011 | ICGN | ↑ Buy | 4,617,045 | $6.00 | $27.7M | by Eclipse Acquisition Corp | Sep 7, 2011 (5d) |
| Apr 14, 2008 | ENCY | ↑ Buy | 1,387,911 | $2.35 | $3.3M | Fn | Apr 15, 2008 (1d) |
| Apr 10, 2008 | ENCY | ↑ Buy | 223,422 | $2.35 | $525K | Fn | Apr 11, 2008 (1d) |
| Apr 8, 2008 | ENCY | ↑ Buy | 2,232,827 | $2.35 | $5.2M | Fn | Apr 9, 2008 (1d) |
| Apr 4, 2008 | ENCY | ↑ Buy | 2,385,833 | $2.35 | $5.6M | Fn | Apr 7, 2008 (3d) |
| Apr 2, 2008 | ENCY | ↑ Buy | 181,909 | $2.35 | $427K | Fn | Apr 3, 2008 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PYXS insiders
Open-market trades in the last 12 months
About Pfizer Inc's insider trades
Pfizer Inc is a 10% owner of Pyxis Oncology (PYXS). Since Apr 2, 2008, it has reported 21 open-market purchases worth $99.2M and 4 sales worth $743.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (12 filings), other transactions (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PYXS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.